ADO CTCL-3 (Tarado): Multicentric therapy protocol for bexarotene (Targretin) monotherapy in pretreated CTCL stage =Ib with clear assignment to a EORTC-Diagnosis - Tarado

Trial Profile

ADO CTCL-3 (Tarado): Multicentric therapy protocol for bexarotene (Targretin) monotherapy in pretreated CTCL stage =Ib with clear assignment to a EORTC-Diagnosis - Tarado

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Bexarotene (Primary)
  • Indications Cutaneous T cell lymphoma
  • Focus Therapeutic Use
  • Acronyms Tarado
  • Most Recent Events

    • 25 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top